NCT01149486View on ClinicalTrials.gov

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Healthy
Interventions
DRUG

Losartan potassium/Hydrochlorothiazide

100/25 mg Tablets

DRUG

Hyzaar®

100/25 mg Tablets

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01149486 - Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter